Skip to main content

Table 1 Characteristics of study groups

From: Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer

Characteristics

Number of PCa patients (%)

Number of BPH patients (%)

Number of patients

90

83

Age, years, mean ± SD

66.1 ± 8.4

63.3 ± 8.7

Race

  

Caucasian

67 (74.44)

66 (79.5)

Black

10 (11.1)

5 (6.0)

Other

13 (14.44)

12 (14.4)

Ethnicity

  

African-american

3 (3.3)

4 (4.8)

Hispanic

5 (5.55)

0 (0)

Unknown

57 (63.3)

47 (56.6)

Other

25 (27.7)

32 (38.55)

Biopsy grade

  

Gleason 5

1 (1.11)

 

Gleason 6

47 (52.22)

 

Gleason 7

37 (41.11)

 

Gleason ≥ 8

5 (5.55)

 

Biopsy stage

  

T1a

1 (1.11)

 

T1c

7 (7.77)

 

T2a

24 (26.66)

 

T2b

3 (3.33)

 

T2c

43 (47.77)

 

T3a

7 (7.77)

 

T3b

5 (5.55)

Â